ICU Medical Inc
$ 129.96
3.11%
17 Apr - close price
- Market Cap 3,248,011,000 USD
- Current Price $ 129.96
- High / Low $ 131.25 / 126.41
- Stock P/E 4332.00
- Book Value 86.03
- EPS 0.03
- Next Earning Report 2026-05-14
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.02 %
- ROE N/A %
- 52 Week High 160.29
- 52 Week Low 107.00
About
ICU Medical, Inc. develops, manufactures and sells medical devices used in infusion therapy and critical care applications worldwide. The company is headquartered in San Clemente, California.
Analyst Target Price
$180.17
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-04 | 2025-11-06 | 2025-08-07 | 2025-05-05 | 2025-02-25 | 2024-11-12 | 2024-08-07 | 2024-05-07 | 2024-02-27 | 2023-11-06 | 2023-08-07 | 2023-05-08 |
| Reported EPS | 1.91 | 2.03 | 1.43 | 1.72 | 2.11 | 1.59 | 1.56 | 0.96 | 1.57 | 1.57 | 1.88 | 1.74 |
| Estimated EPS | 1.71 | 1.42 | 1.5 | 1.28 | 1.482 | 1.25 | 1 | 0.82 | 1.19 | 1.39 | 1.6 | 1.43 |
| Surprise | 0.2 | 0.61 | -0.07 | 0.44 | 0.628 | 0.34 | 0.56 | 0.14 | 0.38 | 0.18 | 0.28 | 0.31 |
| Surprise Percentage | 11.6959% | 42.9577% | -4.6667% | 34.375% | 42.3752% | 27.2% | 56% | 17.0732% | 31.9328% | 12.9496% | 17.5% | 21.6783% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-14 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 1.35 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ICUI
2026-04-18 05:40:25
Wall Street Zen downgraded ICU Medical (NASDAQ:ICUI) from "buy" to "hold." This comes after ICU Medical reported Q4 EPS of $1.91, exceeding estimates, but revenue of $535.9M missed expectations and was down 14.1% year-over-year. The medical instruments supplier has a mixed analyst outlook with an average rating of "Moderate Buy" and institutional ownership around 96%.
2026-04-18 00:09:25
Piper Sandler has maintained an "Overweight" rating for ICU Medical (ICUI) but lowered its price target from $178 to $163. GuruFocus indicates that ICUI is approximately 2.5% overvalued with a GF Value™ of $127.11 against a current price of $130.34, despite a strong GF Score™ of 87/100, which reflects good profitability and valuation but moderate financial strength. Insiders have not reported any buying or selling activity in the last three months.
2026-04-17 14:40:35
Piper Sandler has reduced its price target for ICU Medical stock to $163 from $178, while maintaining an Overweight rating, due to the impact of higher oil prices on freight costs. The firm adjusted its first-quarter organic growth estimates and full-year gross margin assumptions, noting that a $10 per barrel increase in oil prices affects the profit and loss by approximately $2 million. This adjustment aligns with a cautious outlook, despite KeyBanc recently raising its price target for ICU Medical.
2026-04-16 17:20:08
Purcell & Lefkowitz LLP has launched a shareholder investigation into ICU Medical, Inc. (NASDAQ: ICUI) to determine if the company's directors breached their fiduciary duties through recent corporate actions. Shareholders of ICU Medical are invited to contact the firm for more information regarding their rights and options. The law firm specializes in representing shareholders affected by securities fraud and corporate misconduct.
2026-04-14 03:38:54
ICU Medical (ICUI) recently approved a 25% ownership threshold for shareholders to call special meetings, while rejecting a proposal for a 10% threshold. This decision is seen as a moderate step towards increased shareholder influence, aligning with the company's focus on product execution and margin recovery amidst ongoing integration and regulatory challenges. While not a major shift in its core investment narrative, investors should monitor its impact alongside fundamental drivers and potential quality-related costs.
2026-04-10 17:09:47
This article provides an in-depth analysis of Icu Medical Inc. (NASDAQ: ICUI) price dynamics and execution-aware positioning. It highlights weak near and mid-term sentiment, a neutral long-term outlook, and an exceptional risk-reward setup. The analysis includes AI-generated trading strategies tailored for different risk profiles and holding periods, along with multi-timeframe signal analysis.
